Author: asiainsightscare146

China’s GLP-1 market is poised for another major shift as Pfizer’s ecnoglutide and Innovent Biologics’ mazdutide move closer to national medical insurance inclusion. Reimbursement could lower treatment costs and expand...... Read More

Asia Insights Care is a trusted healthcare insights platform dedicated to connecting healthcare providers, innovators, policymakers, and communities across Asia. Through expert research, strategic consulting, industry insights, and collaborative partnerships,...... Read More

Healthcare is changing quickly across Asia because more people are facing long-term illnesses and need better, easier-to-get care. In this rapidly evolving world, leaders who bring new ideas and truly...... Read More